These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8255830)

  • 1. Who should be offered genetic screening?
    Super M
    Postgrad Med J; 1993 Sep; 69(815):669-71. PubMed ID: 8255830
    [No Abstract]   [Full Text] [Related]  

  • 2. Should all pregnant women be offered carrier testing for fragile X syndrome?
    Finucane B
    Clin Obstet Gynecol; 1996 Dec; 39(4):772-82. PubMed ID: 8934029
    [No Abstract]   [Full Text] [Related]  

  • 3. Carrier screening for cystic fibrosis.
    Dungan JS
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):47-59, Table of Contents. PubMed ID: 20494257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for fragile X syndrome: a model for genetic disorders?
    Barnicoat A
    BMJ; 1997 Nov; 315(7117):1174-5. PubMed ID: 9393215
    [No Abstract]   [Full Text] [Related]  

  • 5. What do young people think about screening for cystic fibrosis?
    Cobb E; Holloway S; Elton R; Raeburn JA
    J Med Genet; 1991 May; 28(5):322-4. PubMed ID: 1865469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic fibrosis carrier testing in early pregnancy by general practitioners.
    Harris H; Scotcher D; Hartley N; Wallace A; Craufurd D; Harris R
    BMJ; 1993 Jun; 306(6892):1580-3. PubMed ID: 8329921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of the new genetics for screening for cystic fibrosis.
    Dodge JA
    Lancet; 1988 Sep; 2(8612):672-4. PubMed ID: 2901527
    [No Abstract]   [Full Text] [Related]  

  • 8. Making a (cautious) case for expanding reproductive genetic carrier screens: Australian researchers report success, and caveats, with a simultaneous panel of cystic fibrosis, fragile X syndrome, and spinal muscular atrophy.
    Am J Med Genet A; 2018 Mar; 176(3):510-512. PubMed ID: 29446568
    [No Abstract]   [Full Text] [Related]  

  • 9. Population screening for fragile-X syndrome.
    Bonthron D; Strain L
    Lancet; 1993 Mar; 341(8847):769-70. PubMed ID: 8095681
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for cystic fibrosis.
    Roderick PJ; Chapple J
    Lancet; 1989 Dec; 2(8676):1403-4. PubMed ID: 2574354
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening for carriers of cystic fibrosis. Psychological consequences are unclear.
    Marteau T
    BMJ; 1994 Nov; 309(6966):1429-30. PubMed ID: 7819858
    [No Abstract]   [Full Text] [Related]  

  • 12. Carrier screening for cystic fibrosis.
    Massie J
    Lancet; 2009 Sep; 374(9694):978. PubMed ID: 19766881
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost effectiveness of antenatal screening for cystic fibrosis.
    Cuckle HS; Richardson GA; Sheldon TA; Quirke P
    BMJ; 1995 Dec; 311(7018):1460-3; discussion 1463-4. PubMed ID: 8520332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for cystic fibrosis.
    Holmes LB; Pyeritz RE
    JAMA; 1998 Apr; 279(14):1068-9. PubMed ID: 9546562
    [No Abstract]   [Full Text] [Related]  

  • 15. Active cascade testing for carriers of cystic fibrosis gene.
    Super M; Schwarz MJ; Malone G; Roberts T; Haworth A; Dermody G
    BMJ; 1994 Jun; 308(6942):1462-7. PubMed ID: 8019278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population based prenatal screening for the fragile X syndrome.
    Palomaki GE
    J Med Screen; 1994 Jan; 1(1):65-72. PubMed ID: 8790488
    [No Abstract]   [Full Text] [Related]  

  • 17. Prenatal screening for cystic fibrosis.
    De Braekeleer M
    Lancet; 1994 Jan; 343(8890):172-3. PubMed ID: 7904016
    [No Abstract]   [Full Text] [Related]  

  • 18. Case finding for the fragile X syndrome and its consequences.
    Turner G; Robinson H; Wake S; Laing S; Partington M
    BMJ; 1997 Nov; 315(7117):1223-6. PubMed ID: 9393231
    [No Abstract]   [Full Text] [Related]  

  • 19. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
    J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal screening for cystic fibrosis.
    Doherty RA; Palomaki GE; Kloza EM; Erickson JL; Dostal DA; Haddow JE
    Lancet; 1994 Jan; 343(8890):172. PubMed ID: 7904015
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.